|
Volume 272, Number 46, Issue of November 14, 1997
pp. 29212-29221
Characterization of a Novel, Stage-specific, Invariant Surface
Protein in Trypanosoma brucei Containing an Internal,
Serine-rich, Repetitive Motif*
(Received for publication, August 6, 1997)
Derek P.
Nolan
,
David G.
Jackson
§,
Henry J.
Windle
¶ ,
Annette
Pays
,
Maurice
Geuskens
,
Alain
Michel
,
H. Paul
Voorheis
¶ and
Etienne
Pays
From the Department of Molecular Biology, University of Brussels,
67 rue des Chevaux, B-1640 Rhode St. Genèse, Belgium, the
§ Institute of Molecular Medicine, John Radcliffe Hospital,
Oxford OX3 9DU, UK, the ¶ Department of Biochemistry, Trinity
College, Dublin 2, Ireland, and the Laboratoire de Chimie
Biologique, Universite de Mons-Hainaut, B-7000 Mons, Belgium
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
A new surface membrane protein, invariant surface
glycoprotein termed ISG100, was identified in
Trypanosoma brucei, using catalyzed surface,
radioiodination of intact cells. This integral membrane glycoprotein
was purified by a combination of detergent extraction, lectin-affinity,
and ion-exchange chromatography followed by preparative
SDS-polyacrylamide gel electrophoresis. The protein was expressed only
in bloodstream forms of the parasite, was heavily N-glycosylated, and was present in different clonal
variants of the same serodeme as well as in different serodemes. The
gene for this protein was isolated by screening a cDNA expression
library with antibodies against the purified protein followed by
screening of a genomic library. The nucleotide sequence of the gene
(4050 base pairs) predicted a highly reiterative polypeptide containing three distinct domains, a unique N-terminal domain of about 10 kDa
containing three potential N-glycosylation sites, which was followed by a large internal domain consisting entirely of 72 consecutive copies of a serine-rich, 17-amino acid motif (~113 kDa)
and terminated with an apparent transmembrane spanning region of about
3.3 kDa. The internal repeat region of this gene (3672 base pairs)
represents the largest reiterative coding sequence to be fully
characterized in any species of trypanosome. There was no significant
homology with other known proteins, and overall the predicted protein
was extremely hydrophobic. Unlike the genes for other surface proteins,
the gene encoding ISG100 was present as a single copy.
Although present in the flagellar pocket, ISG100 was
predominantly associated with components of the pathways for endo/exocytosis, such as intracellular vesicles located in the proximity of the pocket as well a large, electron-lucent perinuclear digestive vacuole.
INTRODUCTION
The African trypanosomes are a group of unicellular eukaryotes
responsible for sleeping sickness in man and related diseases in
animals. The life cycle of these parasites, which alternates between
the mammalian host and the tsetse fly vector, is characterized by the
stage-specific expression of two major surface glycoproteins, namely
the variant surface glycoprotein
(VSG)1 and procyclin during
the bloodstream and insect mid-gut stages, respectively. These two
proteins cover the entire surface of the trypanosome and are by far the
most abundant of the surface proteins during these stages of the life
cycle. Although there is a considerable body of data in the literature
concerning the structure, function, and differential expression of VSG
and procyclin (1-3), only relatively recently (for review, see Overath
et al. (4) has attention focused on other surface proteins
located either beneath the surface coats of VSG/procyclin or within the
the flagellar pocket, a specialized invagination of the plasma
membrane, which is involved in the pathways for endo- and exocytosis in
these cells. There are several reasons why interest in these proteins is increasing. First, some of these proteins must be involved in a
range of cellular housekeeping processes, such as the uptake of high
molecular weight ligands and the transport of solutes and ions. Second,
given their functional role, such proteins are unlikely to undergo
antigenic variation in the same manner and extent as the VSG and,
consequently, may represent suitable targets for the development of
vaccines or chemotherapy. Third, even if the development of effective
vaccines against these invariant surface antigens proves to be either
impossible or impractical, the fact remains that the plasma membrane of
these cells represents an important biological interface between host
and parasite and as such is likely to occupy a pivotal position in
multiple signaling pathways, such as those involved in interactions
between the mammalian host and arthropod vector, switching between
different life cycle stages and probably intercellular communication
with other trypanosomes. Arguably, these topics are among the most
exigent areas of research in molecular parasitology at present, and an
important step toward improving our understanding of these processes
must be the identification and characterization of the plasma membrane
proteins that mediate them.
In this respect it is significant that, to date apart from the VSG and
procyclin, only three other surface proteins have been fully
characterized at a molecular and functional level in Trypanosoma brucei: the heterodimeric transferrin receptor (5-7), a
Ca2+-regulated adenylate cyclase (8, 9), and the glucose
transporter (10). Although functional assays have identified receptors
for lipoproteins and lytic factors (11-13) as well as for several
plasma membrane enzymes (14, 15), there is no data available concerning the molecular nature of the proteins responsible. Conversely, the genes
for several putative plasma membrane proteins, termed ESAGs for
expression site-associated genes, have been identified in T. brucei, which appear to code for amphiphatic polypeptides that
contain typical membrane signal sequences and consensus sites for
N-glycosylation, but the function and cellular location of the proteins encoded by these genes has yet to be established (16).
Recently, more direct approaches involving surface labeling of
whole cells using biotinylation or iodination have identified a
number of bloodstream stage-specific, invariant surface glycoproteins or ISGs that were uniformly distributed over the entire surface of the
trypanosome (17-19). The genes for two of these ISGs have been cloned
and code for proteins with N-terminal leader sequences, hydrophilic
extracellular domains, single transmembrane spanning regions as well as
sites for N-glycosylation, and were present as multiple
copies (20, 21). However, no homology with other proteins was observed,
and the function of these ISGs also remains unknown.
Here we describe the isolation, purification, and molecular
characterization of a novel surface protein in T. brucei.
Uniquely, this bloodstream, stage-specific protein contains a large
internal domain consisting entirely of 72 copies of a previously
undescribed amino acid motif. Unlike the genes for other plasma
membrane proteins described so far, the gene for this protein is
present as a single copy.
EXPERIMENTAL PROCEDURES
Materials
All radiochemicals and nitrocellulose filters
were obtained from Amersham International plc, Amersham Buckshire,
United Kingdom. Protein A-Sepharose CL 4B and concanavalin A-Sepharose
4B were purchased from Sigma. N-Glycopepidase F was obtained
from Boehringer Mannheim. Alkaline phosphatase-conjugated and
fluorescein isothiocyanate-labeled anti-rabbit IgG were obtained from
Promega and Amersham, respectively. Other reagents were of the highest
purity available.
Source and Purification of Trypanosomes
Cloned variants of
T. brucei (MITats 1.1, 1.4, 1.5, ILTat 1.21, and AnTat 1.1)
were grown in laboratory rats and purified as described previously
(14). Procyclic forms of T. brucei were produced by
transformation of MITat 1.1 in SDM-79 and maintained in the same medium
as described in a previous report (22).
Surface Labeling of Trypanosomes
All surface labeling
experiments of whole cells were performed using lactoperoxidase/glucose
oxidase or IODO-GEN and carrier-free Na125I (500 µCi/108 cells) as described previously (19).
Purification of ISG100
All steps were performed
at 0-5 °C unless otherwise stated. A sample of surface
radioiodinated cells (5 × 108 cells) was mixed with a
suspension of freshly harvested trypanosomes (~5 × 1010 cells) to provide a marker for ISG purification. The
mixed suspension was washed twice in Tes buffer (50 mM, pH
7.5), NaCl (150 mM), and the pellet was resuspended in the
same buffer (10 ml) containing leupeptin (30 µg/ml), PMSF (0.2 mM), E-64 (20 µM), TLCK (50 µM), and EDTA (1 mM). The cells were lysed by
the addition of 100 ml of distilled deionized water (containing
protease inhibitors) with gentle mixing. After an incubation of 10 min
at 37 °C, 5 ml of NaCl (3 M) was added, and the
suspension was centrifuged at 10,000 × g for 5 min.
The pellet was washed twice in Tes buffer containing protease
inhibitors and was resuspended in the same buffer containing
MgCl2 (5 mM) and DNase I (100 units/1 × 1010 cells) and incubated at room temperature for 5 min.
After DNase treatment this total membrane fraction was centrifuged
(10,000 × g, 5 min) and the pellet was washed twice
and resuspended in 100 ml of Tris buffer (50 mM, pH 7.5)
containing NaCl (150 mM), leupeptin (30 µg/ml), PMSF (0.2 mM), E-64 (20 µM), TLCK (50 µM), and EDTA (1 mM). Detergent extraction of
the membranes was performed by the addition of an equal volume of the
same buffer containing Triton X-100 (2%, w/v) followed by an
incubation on ice for 1 h prior to centrifugation (50,000 × g, 2 h). The supernatant was applied (0.5 ml/min) to a
column (2-ml bed volume) of concanavalin A-Sepharose previously
equilibrated with Tris/NaCl buffer containing Triton X-100 (1%, w/v).
The column was washed with Tris buffer (10 mM, pH 6.5)
containing Triton X-100 (0.1%, w/v), and bound glycoproteins were
eluted with 0.5 M -methylmannoside in the same buffer.
This eluate was applied (0.2 ml/min) to a DEAE-52 column (5-ml bed
volume) equilibrated with Tris buffer (10 mM, pH 6.5)
containing Triton X-100 (0.1%, w/v). The column was washed with the
equilibration buffer (six column volumes), and a linear gradient of KCl
(0-0.5 M), in the same buffer, was applied to the column
(10 column volumes). Fractions (1 ml) were collected throughout, and
their content of radioactivity was measured. Those fractions
corresponding to the peaks of radioactivity were analyzed by SDS-PAGE
and autoradiography as described previously (19). The bands
corresponding to ISG100, which were eluted from the column
by the salt gradient, were excised, reequilibrated with SDS-PAGE sample
buffer, and subjected to preparative SDS-PAGE. The resulting
ISG100 bands, which were detected by autoradiography, were
excised, rehydrated with water, and subsequently used to immunize
rabbits.
Raising Antisera
Polyclonal anti-ISG100
antibodies were raised in rabbits and the IgG fraction was
prepared exactly as described previously (19).
Gels, Immunoblotting, and Immunoprecipitates
SDS-PAGE,
autoradiography, and Western blots were performed as described
previously (19). Detergent lysates were prepared by the method of
Anderson and Blobel (23). Immunoprecipitations were performed by mixing
samples (100 µl) of detergent lysates, corresponding to
107 cells, with the antisera (determined by titration but
routinely 20 µl) followed by an incubation of 30 min at 4 °C. The
antibody-treated lysates were then mixed with a slurry (1:1, v/v) of
protein A-Sepharose CL 4B in phosphate buffer in a ratio of five
volumes of slurry for each volume of antibody added. The mixture was
agitated at 4 °C for at least 2 h before centrifuging, and
washing the resin and elution of the immune complexes was as described
elsewhere (19).
Immunofluoresence Microscopy
Trypanosomes (4 × 107 cells/ml) were fixed in paraformaldehyde (2%, w/v) in
phosphate buffered saline (pH 7.5) at 4 °C for 20 min. The fixed
cells were washed in PBS containing BSA (5%, w/v) and glycine (1 mg/ml). The cells were resuspended in PBS/BSA (2 × 107 cells/ml), and 20 µl were spread gently and uniformly
onto poly-L-lysine-coated glass slides and air dried. After
blocking nonspecific protein binding sites with PBS/BSA the cells were
treated overnight with the antibodies diluted 1/150 in PBS/BSA
containing Tween 20 (0.1%, w/v). The slides were washed with PBS/BSA
prior to treatment with fluorescein isothiocyanate-labeled anti-rabbit
globulin (1/500 in PBS/BSA) for 1 h at room temperature and washed
again before mounting in 50% glycerol (w/v) in PBS containing
1,4-diaza-bicyclo(2,2,2)octane (25 mg/ml). The cells were viewed and
photographed using a Zeiss Axioplan immunofluoresence microscope with
an oil immersion ×100 Plan-Neofluar objective. High resolution
immunofluorescence experiments were performed using a Zeiss Axioskop
microscope equipped with a digital in situ imaging
system.
Immunogold Electron Microscopy
Pleomorphic bloodstream
forms of T. brucei were fixed for 15 min at room temperature
in paraformaldehyde (4%, w/v) and glutaraldehyde (0.1%, w/v) diluted
in cacodylate buffer (0.1 M, pH 7.2). After dehydration in
methanol with progressive lowering of the temperature, they were
embedded in Lowicryl, which was polymerized under UV light at
20 °C. Ultrathin sections recovered on carbon-formvar nickel grids
were floated on PBS containing BSA (1%) and goat serum (10%) for
1 h and then overnight, at 4 °C, on PBS/BSA containing anti-ISG100 antisera (1/100). After three washes in PBS/BSA
containing Tween 20 (0.05%, w/v), the grids were floated for 1 h
on PBS/BSA containing EM goat F(ab)2 anti-rabbit IgG (Biocell) or
protein A (Sigma), both conjugated to 10-nm gold particles (both
diluted 1/100). The grids were washed three times in PBS/BSA containing Tween 20, rinsed in distilled water, and stained with uranyl acetate and lead citrate before being viewed in an AEI 6B electron
microscope at 60 kV.
Cloning and Sequencing the Entire ISG100 Gene
A
cDNA library was constructed in gt11 using poly(A) mRNA
isolated from bloodstream forms of T. brucei (AnTat 1.1) as
described by Gubler and Hoffman (24) using the Amersham cDNA
synthesis and cloning kits. A SalI T. brucei
(AnTat 1.3) genomic library was constructed in EMBL 12 according to
standard methods (25). The gt11 library was screened according to
the supplier's instructions with a few modifications. Non-fat milk
powder (5%, w/v) in Tris-buffered saline, containing Nonidet P-40
(0.05%, w/v) and a bacterial lysate, was used to block nonspecific
binding to the nitrocellulose filters and to dilute the antibodies
(1/1000 of the IgG fraction). The bacterial lysate was prepared by
diluting 1 ml of an overnight culture of the host strain (Y1090) in 50 ml of LB and incubating at 37 °C with shaking for 2-3 h. The
bacteria were collected by centrifugation and resuspended in distilled
deionized water (3 ml), lysed by sonication, and denatured by
incubating the lysate at 100 °C for 4 min. The lysate was diluted
1/100 prior to use. Alkaline phosphatase-conjugated goat anti-rabbit
IgG was used, at a dilution of 1/7500, in accordance with the
supplier's instructions (Promega). Positive plaques were purified by
repeated screening, and the insert cDNAs were subcloned into pUC
vectors. Inserts of positive clones were sequenced on both strands by
the dideoxy chain termination method (25) using the U. S. Biochemical
Corp. Sequenase version 2.0 kit. Sequence analysis was performed using the GCG/Wisconsin software (26).
A partial cDNA obtained from the gt11 library was used to screen
an EMBL 12 genomic library, using 32P-labeled probes
according to standard methods (27) and resulted in the isolation of a
SalI genomic fragment (10 kb) containing the
ISG100 gene. Subsequently, an NlaIII fragment
(5.2 kb) that contained the complete coding region of the
ISG100 gene was isolated from this SalI genomic
fragment and subcloned into the SphI site of pUC18.
Sequencing of the entire NlaIII fragment on both strands represented a major effort and was accomplished by a combination of
primer walking where possible and the generation of a series of nested
exonuclease III deletions using the Erase-a-Base® system obtained from
Promega. This process involved the isolation of clones containing the
NlaIII fragment in both orientations in the SphI
site of the pUC18 vector. Plasmid DNA prepared from these clones was
digested with SacI and XbaI to generate Exo
III-resistant 3 and -susceptible 5 overhangs, respectively. A nested
set of deletions in the target DNA was then prepared by digestion for various times with Exo III according to the supplier's instructions. Since the reiterative region of the gene (~3.7 kb) lacked unique restriction sites, several hundred clones were screened, and in each
case the plasmid DNA was linearized by appropriate restriction enzyme
digestion and subjected to careful size fractionation on agarose gels
to obtain a set of deletion clones that differed by about 200 bp and
spanned the entire repeat region. All of these clones were sequenced by
the dideoxy chain termination method using the 3 -flanking vector
sequence as a primer (reverse primer). It should be stressed that,
throughout, great care and attention was paid to the sequencing and
alignment of these clones. The latter process was aided to some extent
by small variations in sequence of the 51-bp repeat.
DNA and RNA Analysis
The procedures employed for the
isolation of DNA and RNA as well as Southern and Northern blot
hybridizations are described elsewhere (28).
ELISA of the Repeat Motif
A synthetic peptide corresponding
to the consensus sequence of the amino acids predicted from the
nucleotide sequence of the 51-bp repeat region of the gene for
ISG100 was synthesized. The amino acid sequence was N- to
C-terminal, GIAASSLLSSFASSSAV. A stock solution of peptide (5 mg/ml)
was prepared in trifluoroacetic acid and immediately diluted in
coating buffer (NaHCO3, 35 mM; Na2CO3, 15 mM; pH 9.6) to give a
range of peptide concentrations (0.05 to 20 µg/ml). Samples (100 µl) of these peptide solutions were used to coat the wells of a
microtiter plate (Nunc) that had been previously precoated with
poly-L-lysine to enhance adsorption of the peptides as
described previously (29). The wells were washed three times with PBS
and incubated with blocking buffer, Tris-buffered saline containing BSA
2% (TBS/BSA), for 30 min at 37 °C. The wells were washed with with
TBS, and 100 µl of anti-ISG100 polyclonal antibodies,
appropriately diluted in TBS/BSA, were added to each well and incubated
at room temperature for 2 h. After washing with TBS/BSA, alkaline
phosphatase conjugated goat anti rabbit IgG (100 µl, diluted 1/7500
in TBS/BSA) was added to each well, incubated for 1 h at room
temperature, and then each well wash washed several times with TBS.
Finally, 100 µl of alkaline phosphatase assay buffer containing
4-nitophenylphosphate (2 mg/ml) were added to each well. The plates
were incubated at room temperature for 30 min, and the absorption at
405 nm of each well was measured using an automatic plate reader.
Fractionation and Purification of the Flagellar Pocket
Membrane
All steps were performed at 4 °C. Isolated
trypanosomes (5 × 1010 cells) were washed twice in
isotonic sucrose (sucrose, 250 mM; EDTA, 1.5 mM; KCl, 1 mM; Hepes, 5 mM, pH
7.5). The paste of cells was transferred to a chilled mortar, and the
cells were disrupted by grinding with glass Ballotini beads (Sigma acid
washed, 75-200 µm). Grinding was continued until about 75%
disruption was achieved as judged by phase contrast microscopy. The
homogenate was resuspended (~10 ml) in isotonic sucrose containing
leupeptin (40 µg/ml), PMSF (0.2 mM), E-64 (10 µM), TLCK (50 µM). The glass beads were sedimented by centrifugation at 800 rpm (77 × g) for 1 min and washed twice with the same buffer. The combined supernatants
were centrifuged at 2000 × g for 4 min, the
supernatant was removed, and the loose pellet was washed once. The
combined supernatants were centrifuged at 65,000 × g
for 60 min. The high speed pellet was resuspended in no more than 3 ml
of isotonic sucrose buffer and carefully layered onto the top of a
discontinuous sucrose gradient, which consisted of various sucrose
solutions, prepared in Hepes (5 mM, pH 7.5), (KCl, 1 mM), EDTA (1.5 mM), calculated to give the
following final densities: 1.094 g/ml (8 ml), 1.113 g/ml (10 ml), 1.187 g/ml (8 ml), and 1.252 g/ml (6 ml). These densities were based on the
median equilibrium densities of the flagellar pocket membrane (1.11 g/ml), microsomal/endoplasmic reticulum membrane (1.175 g/ml), and the
plasma membrane (1.22 g/ml) (31). The gradient was centrifuged at
58,000 × g for 90 min using an AH629 rotor. After
centrifugation, the material banding at each of the density interfaces,
which corresponded to the flagellar pocket membrane,
microsomal/endoplasmic reticulum membrane, and pellicular plasma
membrane fractions, respectively, as the interface density increased,
was removed, diluted to 35 ml with isotonic sucrose buffer, and
centrifuged at 70,000 × g for 60 min. The pellets were
resuspended in 0.5-1.0 ml of isotonic sucrose buffer. The material
corresponding to the flagellar pocket fraction, i.e. the
material which banded at the 1.094-1.113 g/ml density interface, was
layered onto a continuous sucrose gradient (20 to 45%, 30 ml) over a
54% sucrose cushion (3 ml), both prepared in the Hepes buffer. This
gradient was centrifuged at 58,000 × g for 3 h
using the AH629 rotor. After centrifugation the gradient was
fractionated and screened for the presence of the heterodimeric
transferrin receptor, a marker for the flagellar pocket (5), by Western blots and ELISAs using anti-ESAG7 antibodies. In general the flagellar pocket membranes were visible as a distinct white band about 60% down
the gradient. These membranes were washed with isotonic sucrose buffer,
resuspended in the same buffer (~1 mg/ml), and stored at 80 °C.
The flagellar pocket, microsomal/endoplasmic reticulum, and pellicular
plasma membrane fractions prepared using this protocol, respectively,
represented 0.58 ± 0.25%, 0.48 ± 0.22%, and 4.1 ± 0.9% of the total cellular protein present in the initial homogenate after removal of the glass beads (mean ± S.E. of four
preparations).
RESULTS
ISG100 Is a Bloodstream Stage-specific
Glycoprotein
In a previous report we identified two invariant
surface proteins in bloodstream forms of T. brucei using
surface radioiodination, but noted that other less abundant surface
proteins were also labeled (19). The final steps in the purification of
one of these proteins termed ISG100, for invariant surface
glycoprotein with Mr ~ 100,000, are presented
in Fig. 1. 125I-Labeled
surface glycoproteins that were specifically eluted from a concanavalin
A-Sepharose column were fractionated by ion-exchange chromatography on
DEAE-52. Approximately 60% of the applied radiolabeled proteins did
not adhere to the resin, while the remainder of the labeled proteins
were eluted by the application of a linear salt gradient (Fig.
1A). The majority of retained proteins eluted at relatively
low concentrations of salt (<150 mM), and SDS-PAGE analysis of these fractions demonstrated that the 125I
label was primarily associated with three distinct bands (Fig. 1B). Two of these proteins migrated with an apparent
Mr comparable to that reported previously for
ISG70 and ISG64 (19) and were well resolved
from the slower migrating ISG100. Significantly, only a
single band of radioactivity was obtained when the material corresponding to ISG100 was excised from these gels and
reelectrophoresed on a preparative SDS-PAGE gel. In a typical
preparation 6.7 ± 0.3 µg of purified ISG100 was
obtained from 36 ± 2.5 mg of the total membrane fraction obtained
after osmotic rupture of cells.
Fig. 1.
Purification of ISG100 from
bloodstream forms T. brucei. A, the elution
profile of 125I-labeled glycoproteins from the DEAE-52
ion-exchange column as described under "Experimental Procedures."
Symbols: labeled protein counts/min (CPM) ( ), [KCl]
( ). B, an SDS-PAGE/autoradiogram analysis of samples from
the first 11 fraction obtained from the ion-exchange column after the
application of the salt gradient. Bands corresponding to
ISG100 were excised, treated as described under
"Experimental Procedures," and subjected to preparative electrophoresis as shown on the extreme right of the panel. The molecular weight marker proteins were myosin (Mr = 205,000), -galactosidase (Mr = 116,000),
phosphorylase b (Mr = 97, 400),
bovine serum albumin (Mr = 68,000), and
ovalbumin (Mr = 46,000).
[View Larger Version of this Image (39K GIF file)]
Antibodies against purified ISG100 allowed the specific
immunoprecipitation of the protein from detergent extracts of cells surface-labeled with 125I or subjected to metabolic
labeling with [35S]methionine (Fig.
2A). Significantly, all of the
ISG100 was recovered exclusively in the membrane fraction
following osmotic rupture of cells (Fig. 2A). Repeated
washing of this fraction with NaCl (0.5 M) failed to
release detectable amounts of ISG100 (data not shown),
whereas the protein was readily solublized by detergents as observed
during the purification procedure. These data indicated that
ISG100 was an integral rather than peripheral membrane
protein or attached to the membrane by a glycosylphosphoinositol anchor in the same manner as the VSG.
Fig. 2.
Immunoprecipitation of
ISG100. Autoradiograms of SDS-PAGE gels of various
immunoprecipitations. A, lanes 1-4 present immunoprecipitates of 125I-surfaced labeled bloodstream
forms of T. brucei (MITat 1.1) treated as follows: untreated
(1) and trypsin-treated cells (2), cellular
pellet (3), and soluble fraction (4) obtained
after osmotic rupture of the cells. Also presented are
immunoprecipitates from lysates of bloodstream (MITat 1.1) (lanes
5 and 6) or procyclic (lanes 7 and
8) forms of T. brucei metabolically labeled with [35S]methionine using preimmune sera (lanes 5 and 7) or antibodies against ISG100 (lanes
6 and 8). B, immunoprecipitates of
125I-surfaced-labeled bloodstream forms of different cloned
variants of T. brucei (MITat 1.4) incubated alone
(lane 1) or with N-glycopeptidase (lane
2), MITat 1.5 (lane 3), and ILTat 1.21 (lane
4). Metabolic labeling with [35S]methionine,
enzymatic treatments (trypsin/N-glycopeptidase F), and
osmotic rupture of the cells were performed exactly as described previously (19). Details of the immunoprecipitations, SDS-PAGE, and
autoradiography are provided under "Experimental Procedures." The
molecular weight markers are as described in the legend to Fig.
1.
[View Larger Version of this Image (60K GIF file)]
An unusual feature of ISG100 was its relative resistance to
proteolytic cleavage in whole cells. All of the labeled
ISG100 remained associated with the cellular pellet, and
there was no evidence of proteolytic degradation of the protein,
following mild trypsin treatment of intact radioiodinated cells (Fig.
2A). Similar results were obtained with low concentrations
of papain, pepsin, and chymotrypsin (data not shown), whereas other
ISGs and the VSG were readily cleaved from the cell surface under these conditions (19). However, purified ISG100 was sensitive to
these proteases (data not shown). Immunoprecipitation of
ISG100 metabolically labeled with
[35S]methionine (Fig. 2A) demonstrated that
the protein was stage-specific and was expressed only in bloodstream
forms of T. brucei. These results also eliminated the
possibility that the ISG100 was a host protein adsorbed to
the surface coat of the cell.
The binding and specific elution of ISG100 from
concanavalin A-Sepharose indicated the presence of covalently bound
carbohydrate. This view was supported by the effect of treatment of the
immunoprecipitated protein with endoglycopeptidase F, which resulted in
the complete loss of the 100-kDa band and the concomitant appearance of
a band with apparent Mr ~ 55,000 (Fig.
2B, lane 2). An intermediate band, Mr ~ 70,000, was also detected when shorter
incubations were employed, suggesting the presence of two distinct
N-linked glycosyl chains (data not shown). The large
difference in the electrophoretic mobility of the protein after
deglycosylation clearly indicated the presence of extensive
N-linked carbohydrate chains. The antibodies also
efficiently recognized the deglycosylated form of the protein (data not
shown). Finally, antibodies against ISG100 purified from
the MITat 1.1 clone also allowed the specific immunoprecipitation of
the same labeled protein from other clonal variants (Fig.
2B).
Isolation of the Gene Coding for ISG100
A
T. brucei bloodstream form expression library was screened
with polyclonal antibodies against purified ISG100.
Approximately 2 × 105 clones were screened and 17 positive clones were obtained, which were purified by repeated
screening. Restriction digest and Southern blot analysis of the DNA
prepared from these clones indicated that the cDNA inserts were all
related, and the largest of these inserts (~2.1 kb) was subcloned
into pUC18. Sequence analysis of this insert demonstrated that it was
composed almost entirely of a 51-bp repeat element with the exception
of a unique sequence of about 100 bp located at one end (Fig.
3). The repeat region lacked sites for
most restriction enzymes, including frequent cutters, such as
RsaI, but digestion with PvuII released a unique 51-bp repeat fragment (data not shown). Although this cDNA was incomplete and lacked both a poly(A) tail and the 5 mini exon common
to all trypanosomal mRNAs, the nucleotide sequence suggested that
this region encoded a polypeptide containing a repetitive motif.
Fig. 3.
Structure of the ISG100 gene in
T. brucei. The upper map presents a
physical map of the genomic environment of the ISG100 gene
including the SalI 10-kb fragment isolated from the genomic
library. The lower map presents a detailed representation of
the 5.2-kb NlaIII fragment containing the entire
ISG100 gene. The boxed regions represent the
predicted open reading frame, with the solid boxes
representing the unique N- and C-terminal domains, and the open
box represents the internal region composed of the 51-bp repeat
element. The scale shown applies only to the map of the
NlaIII fragment. Restriction site abbreviations are as
follows: N, NlaIII; R,
RsaI; H, HpaI. For clarity the
PstI site adjacent to the 5 NlaIII site is not
shown (see Southern blot analysis in Fig. 6A).
[View Larger Version of this Image (11K GIF file)]
To clone the entire ISG100 gene, a SalI genomic
library was screened (1.5 × 105 clones) with the
partial cDNA and resulted in the isolation of five positive clones,
all of which contained the same 10-kb SalI fragment.
Digestion of this genomic fragment with Nla III yielded a
unique fragment that strongly hybridized with the ISG100
cDNA probes (Figs. 3 and 6). This fragment was subcloned into the
SphI site of pUC18, and the entire region was carefully
sequenced on both strands (see "Experimental Procedures" for
details).
Fig. 6.
Southern and Northern blot analysis of the
ISG100 gene. A, genomic DNA from bloodstream
forms of T. brucei (AnTat 1.1) was digested with the
following restriction enzymes: lane 1, RsaI; lane 2, NlaIII; lane 3,
PvuII; lane 4, PstI; lane
5, SpeI and PstI; lane 6,
SpeI; lane 7, SalI and
PstI; lane 8, SalI and
SpeI; lane 9, SalI. Digested DNA was
separated on an agarose gel (1%) blotted to Hybond-C extra
nitrocellulose filters and probed with 32P-labeled
NlaIII fragment as shown in Fig. 3. The scale is included to
illustrate the size of the RsaI and NlaIII
fragments. B, total poly(A+) RNA (10 µg) from
stumpy bloodstream forms (lane 1), long slender bloodstream
forms, AnTat 1.1 (lane 2) and procyclic forms (lane 3) were separated on a formaldehyde agarose gel, transferred to Hybond-C extra nitrocellulose filters, and probed with
32P-labeled partial cDNA (2.1 kb) obtained from the
initial gt11 screening.
[View Larger Version of this Image (62K GIF file)]
Predicted Amino Acid Sequence
Analysis of the sequence of
this NlaIII genomic fragment (5.2 kb) predicted the presence
of a single, large open reading frame of 4050 bp (Fig.
4A), which
was in good agreement with the size of the single
transcript detected on Northern blots ~4.4 kb (see Fig.
6B). This open reading frame started and finished with
initiation and termination codons located at positions 760 and 4810 downstream from the Nla III site and consisted of a unique
282-bp 5 -sequence followed by a long internal sequence (3672 bp)
consisting entirely of 72 copies of a 51-bp repeat element and ended
with a short nonreiterative 3 -sequence of 96 bp (Fig. 4A).
Thus, the predicted polypeptide (~127 kDa) consisted of three
distinct domains, an N-terminal domain of about 10 kDa that contained
three potential N-glycosylation sites, which was followed by
a large internal domain consisting of about 72 consecutive copies of a
serine-rich, 17-amino acid motif (~113 kDa) and terminated with a
short C-terminal region of about 3.7 kDa (Fig. 4B).
Fig. 4.
Nucleotide and deduced amino acid sequence of
ISG100. A, the nucleotide sequence of the
NlaIII genomic fragment containing the ISG100
gene. The initiation (760) and termination (4810) codons as well as the
nucleotide sequence of the first and last of the 51-bp repeats are
underlined. B, the deduced amino acid sequence of
ISG100. The first and last of the 17-amino acid repeats as well as the three potential N-glycosylation sites and the
single tyrosine residue are underlined. C, the consensus
sequence of the 17-amino acid repeat motif presented in the
one-letter code. Variations in the motif are present
below in the position that they occur in the repeat motif.
Where variation occurs, the subscripts refer to the number
of times the relevant amino acid occurred in the 72 repeats.
[View Larger Versions of these Images (73 + 73K GIF file)]
To confirm the amino acid sequence, a synthetic peptide was prepared
corresponding to the amino acid repeat motif predicted from the
nucleotide sequence to be in frame with the initiation codon. This
serine-rich peptide was readily recognized by polyclonal antibodies
raised against purified ISG100 in ELISAs (Fig.
5A). Moreover, the predicted
polypeptide contained only a single tyrosine residue located three
residues from the C-terminal histidine and 16 amino acids downstream
from the single tryptophan present in the entire protein. This sequence
was also confirmed by peptide mapping experiments on the purified
ISG100 with N-chlorosuccinimide (100 mM), under conditions specific for cleavage at tryptophanyl peptide bonds (19), which resulted in the complete loss of the 125I label but only a slight decrease in the
Mr as judged by autoradiography and Western blot
analysis of the treated protein (data not shown). A hydrophobicity plot
demonstrated that ISG100 was extremely hydrophobic, mainly
due to the hydrophobic nature of the repeat motif (Fig. 5B).
Interestingly, the N-terminal region lacked an obvious hydrophobic leader sequence, while the short hydrophobic C-terminal domain was
predicted to form a C-terminal transmembrane-spanning region (see
"Discussion"). Although searches through the protein data bases did
not reveal any significant homology with any other known sequences or
motifs, certain aspects of the reiterative region, which represents the
largest such coding sequence to be fully characterized in any species
of trypanosome, are worthy of comment. First, the sequence was highly
conserved with a total of 12 out of 17 of the residues of the motif,
which included the central serine-rich core of 10 amino acids, being
absolutely invariant throughout all of the 72 repeats. Second, sequence
variability of the repeat motif was concentrated in the terminal three
residues and, to a far lesser extent, in the second and fourth
positions of each repeat (Fig. 4C). Third, amino acid
substitutions in the repeat were characterized by a high degree of
specificity and positional fidelity. For example, the only variable
serine or leucine residues in the motif were always replaced by a
cysteine or proline, respectively, while the terminal residue of each
repeat was either threonine or alanine (Fig. 4C). Fourth,
positional variations appeared to occur in blocks within the
reiterative region, as best exemplified by substitution of methionine
for isoleucine at position 15 of the repeat motif. Finally, both the positional and selective fidelity of codon usage of nucleotides in the
51-bp element of the repeat unit were highly conserved, as best
demonstrated by the serine codon usage.
Fig. 5.
ELISA analysis of the repeat motif and
hydropathy plot of ISG100. A, ELISA over a range
of concentrations of the peptide corresponding to serine-rich
repetitive motif (GIAASSLLSSFASSSAV) of ISG100 using
polyclonal antibodies against the purified ISG100 (diluted
1/600). No signal above background was detected in the absence of
anti-ISG100 antibodies or with preimmune serum over the
concentration range of peptide employed. The insert presents the ELISA response as function of antibody dilution at a fixed amount
of peptide (5 ng/well). Each measurement represents the mean of
triplicate determinations. B, hydropathy plot for
ISG100 from the predicted sequence of amino acids by the
method of Kyte and Doolittle (30). The N- and C-terminal regions that
flank the internal repeat are indicated by solid
lines.
[View Larger Version of this Image (19K GIF file)]
Fig. 5A was employed as a calibration curve to estimate the
amount of repeat units in samples of ISG100 obtained by
electroelution of the band from SDS-PAGE gels of immunoprecipitates of
125I-labeled cells. These samples were subjected to ELISAs
as described for the synthetic peptide, and a value of 32.8 ± 6.6 ng of repeat/107 cells was obtained. Given molecular
weights for the peptide and whole protein of 1554 and 126,439, respectively, it was calculated from this result that each cell
contains 17,600 ± 3,600 copies of ISG100, which is
3-fold lower than that reported for ISG70 (19). Although
this estimate was approximate since it assumes that the antibodies were
primarily directed against the repeat motif as well as an identical
response in ELISAs on the synthetic peptide and the whole protein, the
low copy number was consistent with the low yield of purified
protein and the low number of clones obtained from the screening of
cDNA libraries compared with the more abundant
ISG70.
Genomic Organization and Transcription of the ISG100
Gene
Genomic DNA from T. brucei AnTat 1.1 was digested
with several restriction enzymes, including PvuII. The
pattern obtained was consistent with the view that the gene was present
as a single copy (Fig. 6A).
The results from zooblots demonstrated that the ISG100 gene
was also present in the subspecies T. brucei rhodesiense, and T. brucei gambiense, and the subgenus Trypanosoma
evansi, but was absent in other related species, such as
Trypanosoma congolense, Trypanosoma cruzi, and
Crithidia fasciculata (data not shown). The stage-specific
nature of the expression of ISG100 was confirmed by
Northern blots, which showed that a single transcript (~4.4 kb) was
present in bloodstream long slender and stumpy forms but was absent in
procyclic forms (Fig. 6B).
Cellular Localization of ISG100
Antibodies
against ISG100 did not react with live cells, but the
protein was readily detected using immunofluorescent antibody staining
of fixed cells (Fig. 7A).
Although the relative resolution of these experiments precluded an
unequivocal cellular localization, it was clear that ISG100
was not uniformly distributed over the surface of the cell, as observed
for ISG70 (19), but was concentrated as an intense spot in
the posterior region of the cell close to the expected area of the
flagellar pocket. This view was supported by the results of Western
blots (Fig. 7B), which demonstrated an enrichment of
ISG100 in the flagellar pocket fraction as opposed to the
pellicular surface membrane, as was also the case for ESAG7, a
component of the heterodimeric transferrin receptor (5, 7). The
distribution of both of these proteins differed from the
Ca2+-ATPase of the endoplasmic reticulum (TBA1)
(32) and ISG70 (19), which were localized predominantly in
the endoplasmic reticulum and plasma membrane fractions, respectively.
An unequivocal cellular localization of ISG100 was obtained
by immunogold electron microscopy (Fig.
8) and high resolution immunofluorescence
(Fig. 9). In addition to the flagellar
pocket membrane and membranar-vesicular material present in the lumen
of the flagellar pocket, gold particles were predominantly associated
with the membrane and heterogeneous contents of a large
electron-lucent, digestive vacuole and collecting tubules located in
close proximity to the flagellar pocket (33). This cellular location
was confirmed by high resolution immunofluorescence experiments on
cells stained with 4,6-diamidino-2-phenylindole, to illustrate the
position of the kinetoplast and nucleus (Fig. 9). Clearly, most of the
fluorescence corresponding to ISG100 was concentrated in a
large perinuclear compartment but also extended, with decreasing
intensity, in a posterior direction toward the flagellar pocket. Indeed
the fluorescence distribution of ISG100 was almost
identical to that observed for certain host apoliproteins taken up by
the endocytic pathway in trypanosomes (34).
Fig. 7.
Immunofluorescent and immunoblotting
localization of ISG100. A, fixed bloodstream
forms were examined by immunofluorescent or phase contrast microscopy
using antibodies against ISG100 or ISG70 as
indicated. B, Western analysis of flagellar pocket membrane (lane 1), endoplasmic reticulum/lysosomal (lane
2), and plasma membrane (lane 3) fractions (10 µg/lane), prepared as described under "Experimental Procedures,"
were probed with antibodies against ISG100, ESAG7,
ISG70, or the Ca2+-ATPase of the endoplasmic
reticulum (TBA1) (32). The heterogeneous material migrating
between 58 and 70 kDa detected with anti-ESAG7 antibodies represents a
cross-reaction with the closely related ESAG6 component of the
heterodimeric transferrin receptor.
[View Larger Version of this Image (44K GIF file)]
Fig. 8.
Immunogold electron microscopy localization
of ISG100. Immunogold localization of
ISG100 in ultrathin sections of Lowicryl-embedded pleomorphic bloodstream forms of T. brucei using Fab
fragments of goat anti-rabbit IgG conjugated to 10-nm gold particles
prepared as described under "Experimental Procedures" (panels
a and b). The gold particles are observed over
membranar structures inside the flagellar pocket (fp) but
were mostly associated with the membrane and heterogeneous contents of
a large electron-lucent, digestive vacuole (DV). In
addition, tubules (t) of the collecting membrane system were
also labeled as shown on the left side of panel b. After
Lowicryl embedding without OsO4 surface fixation, the
limiting membrane of this digestive vacuole was not well defined, but
is clearly shown in panel c after treatment under standard fixation and embedding conditions (glutaraldehyde/OsO4),
f, flagellum; m, mitochondria.
Bar = 0.1 µm.
[View Larger Version of this Image (145K GIF file)]
Fig. 9.
High resolution immunolocalization of
ISG100. Fixed bloodstream forms were examined by
immunofluorescent microscopy using antibodies against
ISG100. After washing the cells were mounted in PBS
containing glycerol (50%, v/v) and 4,6-diamidino-2-phenylindole (0.1 µg/ml) to indicate the nuclear and kinetoplast DNA. The cells were
viewed with a Zeiss Axioskop microscope equipped with a digital in situ imaging system. The position of the nuclear and
kinetoplast DNA is indicated by arrows marked N
and K, respectively, while the ISG100
fluorescence associated with the perinuclear vacuole and flagellar
pocket are indicated by the arrow and arrowhead, respectively.
[View Larger Version of this Image (110K GIF file)]
DISCUSSION
A novel, bloodstream stage-specific, invariant surface
glycoprotein from bloodstream forms of T. brucei, termed
ISG100, has been identified, purified, and characterized.
This protein differs significantly from all previously characterized
surface proteins in trypanosomes (4). First, ISG100
contains a large, internal domain that is composed entirely of a
previously undescribed serine-rich, repetitive motif that represents
91% of the coding frame. Second, the protein is not uniformly
distributed over the cellular surface but is specifically associated
with elements of the endocytic pathway, including the flagellar pocket
as well as intracellular vesicles and a large perinuclear,
lysosomal-like vacuole. Third, ISG100 is encoded by a
single copy gene, whereas all other trypanosomal plasma membrane
proteins characterized so far are either present as tandem repeats
and/or part of multigene families (4).
In addition to procyclin (3), several other reiterative proteins have
been identified in African trypanosomes. Most of these proteins are
associated with the cytoskeleton, are not stage-specific, and are
characterized by repeats with periodicities larger the repeat element
in ISG100 (35-38). Although not fully characterized, two
other membrane proteins containing internal repeats have been identified in T. brucei. One of these proteins, termed CRAM,
was located in the flagellar pocket (39), while the other was present in the membranes of the vesicular network that underlies the flagellar pocket (40). Although these proteins share a similar cellular location
to that observed for ISG100, both of these proteins
contained shorter repeat units (8 or 12 residues) that were very
hydrophilic and rich in acidic amino acids. Indeed, hydrophilic repeats
containing a preponderance of acidic amino acids are typical features
of reiterative domains in several parasitic taxa (41-45), and it has been suggested that they play a role in the perturbation of the immune
response of the host (46, 47). These considerations argue for an
alternative functional role for ISG100, which may represent
of a new class of reiterative proteins in parasitic protozoa containing
hydrophobic rather than hydrophilic repeats.
There was a significant discrepancy between the size of
ISG100 predicted from the open reading frame (~127 kDa)
and the Mr estimated from its electrophoretic
mobility on SDS-PAGE gels (~100,000) which was even more apparent
after deglycosylation (~55,000). A number of reasons suggest that
this discrepancy was not due to proteolytic cleavage of the protein, as
observed for the low density lipoprotein receptor in T. brucei (48). First, the purification was performed in the presence
of a broad range of protease inhibitors. Second, only a single band
(Mr = 100,000) was detected in Western blots of
whole cells and in immunoprecipitations from detergent lysates prepared
by boiling in SDS, and there was no indication of proteolytic
degradation of the protein under these conditions. Third, this band
contained both N-linked sugars and the 125I
label, and the amino acid sequence of the protein demonstrated that the
only potential N-glycosylation sites and tyrosine to be
radioiodinated were located in the N-terminal domain and at the C
terminus, respectively. Thus, the 100-kDa band almost certainly represents the complete protein. The most likely explanation for the
discrepancy was an aberrant electrophoretic mobility of
ISG100 on SDS-PAGE gels. Indeed, this is a feature of
certain hydrophobic proteins, such as the lac permease which appears to
bind relatively high amounts of SDS and has an unusually high
electrophoretic mobility on SDS-PAGE gels (49).
The presence of three distinct domains in ISG100 allows the
construction of a possible model for the organization of the protein in
the membrane. Although the short N-terminal nonrepetitive domain lacked
an obvious hydrophobic leader sequence, this relatively hydrophilic
region may represent an extracellular domain, since the effect of
treatment with endoglycopeptidase F demonstrates that
ISG100 contains N-linked carbohydrate.
Significantly, this N-terminal region contains the only possible sites
for N-glycosylation in the entire protein, and since
N-glycosylation normally takes place only on the luminal
side of the endoplasmic reticulum, this region is likely to be
externally disposed (50). The hydrophobic nature of the repeat region
suggests that this reiterative domain is associated with the lipid
bilayer, since thermodynamic considerations make it unlikely that such
a long hydrophobic stretch could be easily accommodated within an
aqueous environment (51). Precisely how might the repeat motif be
arranged in the plasma membrane? A classic helical
membrane-spanning region with connector loops seems an implausible
arrangement for the repeat motif, since it is probably too short (17 residues as opposed to the 25 or more required for such a
configuration). Moreover, the presence of such a large number of
consecutive membrane-spanning elements in a single protein would be
unprecedented. An alternative possibility is that the repeat element
assumes a form of monotopic configuration (52) with hairpin loops that
are hydrophobically associated with the membrane but do not pass all
the way through the bilayer. Another possibility is that this
repetitive domain forms a membrane-associated strand structure as
has been proposed for some well studied membrane proteins, for example
the adenine nucleotide translocator (53, 54). Whatever the arrangement
of this region it seems reasonable to assume that the basic structural
organization of the reiterative domain is determined by the invariant
serine-rich, central 10-amino acid core of the repeat motif with the
amino acid substitutions in the variable positions contributing to the folding of this core. The C-terminal domain consists of 32 residues and
includes a hydrophobic stretch predicted to be sufficiently long to
form a transmembrane-spanning region. In support of this view was the
finding that the only tyrosine residue in the entire protein was
located three residues from the C-terminal histidine. Clearly, this
tyrosine must be accessible to the external medium since
125I surface labeling was performed under conditions where
only externally disposed tyrosine residues are iodinated (19). Thus, it
seems reasonable to conclude that the C-terminal region consists of a
transmembrane-spanning region with the terminal residues exposed to the
external environment. Taken together, this leads to a topographic model
for ISG100 in which the internal repeat domain is
associated with the lipid bilayer, possibly only on one side, and is
flanked by a short extracellular N-terminal domain containing extensive N-linked carbohydrate chains and a transmembrane span with
the extreme C-terminal residues exposed at the external surface (Scheme 1). This topological arrangement is
consistent with the resistance of the protein to externally added
proteases as well as the fact that the protein was not accessible to
antibodies in intact cells but was readily radioiodinated.
Scheme 1.
Schematic representation of the proposed
topographic organization of ISG100 in the plasma
membrane. The possible organization of ISG100 in the
surface or vacuolar membrane (not to scale). The hydrophobic
reiterative region is presented as a boxed region within the
bilayer, while the proposed extracellular N-terminal domain, containing
the two N-linked chains (Y), and C-terminal transmembrane spanning region, as well as the five N- and C-terminal amino acids are also shown.
[View Larger Version of this Image (15K GIF file)]
The lack of a significant homology with any known protein sequences or
motifs means that it was not possible to ascribe with certainty a
function to this protein at present. Nevertheless, since expression of
ISG100 is restricted to the bloodstream form, it seems
reasonable to assume that it is required for life in the mammalian
host. The cellular localization of ISG100 demonstrated that
the majority of the protein was located in a perinuclear lysosomal-like
vacuole, as well as smaller endosomal-like vesicles, and probably
labeling with 125I occurs only when the protein is present
in the flagellar pocket membrane. Whether ISG100 can cycle
between these intracellular compartments and the flagellar pocket, as
has been reported for another protein termed CB1-gp (55), remains to be
established. Interestingly, CB1-gp shares a number of features in
common with ISG100. For example this protein was also
bloodstream stage-specific, contained extensive N-linked
carbohydrate chains, and could be surface-labeled in whole cells while
in the flagellar pocket by sulfo-sulfosuccinimidyl-6-(biotinamido)hexanoate-biotin. Whether both
proteins are related is uncertain at present since no sequence data is
available for CB1-gp but this glycoprotein appears to have a
significantly higher Mr (~ 180,000) than does
ISG100.
Given its cellular location, it is tempting to speculate that
ISG100 may play a role in the pathways for endocytosis.
However, it seems unlikely that ISG100 is a receptor for
ligand uptake, since only a small region of the protein may be actually
exposed to the extracellular environment. Alternatively, in view of the repetitive nature of the protein, it seems more likely that
ISG100 may have a structural role in the compartments
involved in intracellular traffic in T. brucei. Currently,
gene knockout experiments, designed to take advantage of the fact that
the gene is present as a single copy, are underway in an attempt to
establish the function of this unusual surface protein.
FOOTNOTES
*
This work was supported by research contracts with the
Communauté Française de Belgique, the Interuniversity Poles
of Attraction Programme of the Belgian State Prime Minister's
Office the Federal Office for Scientific, Technical and Cultural
Affairs and the European Commission Biotech Programme (DG XII).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) Y14833.
Supported by a fellowship from the European Commission (DGXII)
Biotech Program. To whom correspondence should be addressed. Tel.:
32-2-6509627; Fax: 32-2-6509625; E-mail: dnolan{at}dbm.ulb.ac.be.
1
The abbreviations used are: VSG, variant surface
glycoprotein; ISG, invariant surface glycoprotein; PMSF,
phenylmethylesulfonyl flouride; PAGE, polyacrylamide gel
electrophoresis; TBS, Tris-buffered saline; PBS, phosphate-buffered
saline; BSA, bovine serum albumin; ELISA, enzyme-linked immunoadsorbent
assay; Tes,
2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic acid; TLCK, 1-chloro-3-tosylamido-7-amino-2-heptanone; bp, base pair(s); kb, kilobase pair(s).
ACKNOWLEDGEMENTS
We give special thanks to D. Franckx for
photographic work and Dr. D. Perez-Morga for assistance with high
resolution immunofluorescence experiments.
REFERENCES
-
Borst, P.
(1986)
Annu. Rev. Biochem.
55,
701-732
[CrossRef][Medline]
[Order article via Infotrieve]
-
Pays, E., and Steinert, M.
(1988)
Annu. Rev. Genet.
22,
107-126
[CrossRef][Medline]
[Order article via Infotrieve]
-
Roditi, I., and Pearson, T. W.
(1990)
Parasitol. Today
6,
79-82
[CrossRef][Medline]
[Order article via Infotrieve]
-
Overath, P., Chaudri, M., Steverding, D., and Ziegelbauer, K.
(1994)
Parasitol. Today
10,
53-58
-
Salmon, D., Geuskens, M., Hanocq, F., Hanocq-Quertier, J., Nolan, D., Rubin, L., and Pays, E.
(1994)
Cell
78,
75-86
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ligtenberg, M. J. L., Bitter, W., Kieft, R., Steverding, D., Janssen, H., Calafat, J., and Borst, P.
(1994)
EMBO J.
13,
2565-2573
[Medline]
[Order article via Infotrieve]
-
Chaudri, M., Steverding, D., Kittelberger, D., and Overath, P.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6443-6447
[Abstract/Free Full Text]
-
Rolin, S., Halleux, St., Van Sande, J., Dumond, J. E., Pays, E., and Steinert, M.
(1990)
Exp. Parasitol.
71,
350-352
[CrossRef][Medline]
[Order article via Infotrieve]
-
Paindavoine, P., Rolin, S., Van Assel, S., Geuskens, M., Jauniaux, J. C., Dinsert, C., Huet, G., and Pays, E.
(1992)
Mol. Cell. Biol.
12,
1218-1225
[Abstract/Free Full Text]
-
Bringaud, F., and Baltz, T.
(1993)
Mol. Cell. Biol.
13,
1146-1154
[Abstract/Free Full Text]
-
Coppens, I., Baudhuin, P., Opperdoes, F. R., and Courtoy, P. J.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
6753-6757
[Abstract/Free Full Text]
-
Bastin, P., Stephan, A., Raper, J., Saint-Remy, J.-M., Opperdoes, F. R., and Courtoy, P. J.
(1996)
Mol. Biochem. Parasitol.
76,
43-56
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hager, K. M., Pierce, M. A., Moore, D. R., Tyler, E. M., Esko, J. D., and Hajduk, S. L.
(1994)
J. Cell Biol.
126,
155-167
[Abstract/Free Full Text]
-
Voorheis, H. P., Gale, J. S., Owen, M. J., and Edwards, W.
(1977)
Biochem. J.
180,
11-24
-
Schell, D., Stierhof, Y. D., and Overath, P.
(1990)
FEBS Lett.
271,
67-70
[CrossRef][Medline]
[Order article via Infotrieve]
-
Alexandre, S., Guyaux, S., Murphy, N. B., Coquelet, H., Pays, A., Steinert, M., and Pays, E.
(1988)
Mol. Cell. Biol.
8,
2367-2378
[Abstract/Free Full Text]
-
Jackson, D. G., and Voorheis, H. P.
(1990)
Biochem. Soc. Trans.
18,
1032-1033
[Medline]
[Order article via Infotrieve]
-
Ziegelbauer, K., and Overath, P.
(1992)
J. Biol. Chem.
267,
10791-10796
[Abstract/Free Full Text]
-
Jackson, D. G., Windle, H. J., and Voorheis, H. P.
(1993)
J. Biol. Chem.
268,
8085-8095
[Abstract/Free Full Text]
-
Ziegelbauer, K., Multhaup, G., and Overath, P.
(1992)
J. Biol. Chem.
267,
10797-10803
[Abstract/Free Full Text]
-
Ziegelbauer, K., Rudenko, G., Kieft, R., and Overath, P.
(1995)
Mol. Biochem. Parasitol.
69,
53-63
[CrossRef][Medline]
[Order article via Infotrieve]
-
Brun, R., and Schonenberger, M.
(1979)
Acta Trop.
36,
289-292
[Medline]
[Order article via Infotrieve]
-
Anderson, D. J., and Blobel, G.
(1983)
Methods Enzymol.
96,
111-120
[Medline]
[Order article via Infotrieve]
-
Gubler, U., and Hoffman, B. J.
(1983)
Gene (Amst.)
25,
263-269
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sambrook, J., Fritsch, E. F., and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. H., and Roe, B. A.
(1980)
J. Mol. Biol.
143,
161-178
[CrossRef][Medline]
[Order article via Infotrieve]
-
Devereux, J., Haeberli, P., and Smithies, O.
(1984)
Nucleic Acids Res.
12,
387-395
-
Pays, E., Delronche, M., Lheureux, M., Vervoot, T., Bloch, J., Gannon, F., and Steinert, M.
(1980)
Nucleic Acids Res.
8,
5965-5981
[Abstract/Free Full Text]
-
Hobbs, R. N.
(1989)
J. Immunol. Methods
117,
257-266
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kyte, J., and Doolittle, R. F.
(1982)
J. Mol. Biol.
157,
105-132
[CrossRef][Medline]
[Order article via Infotrieve]
-
McLaughlin, J.
(1982)
J. Immunol.
128,
2656-2663
[Abstract]
-
Nolan, D. P., Revelard, P., and Pays, E.
(1994)
J. Biol. Chem.
269,
26045-26051
[Abstract/Free Full Text]
-
Langreth, S. G., and Balber, A. E.
(1975)
J. Protozool.
22,
40-53
[Medline]
[Order article via Infotrieve]
-
Hager, K. M., and Hajduk, S. L.
(1997)
Nature
385,
823-826
[CrossRef][Medline]
[Order article via Infotrieve]
-
Schneider, A., Hemphill, A., and Seebeck, T.
(1988)
Science
241,
459-462
[Abstract/Free Full Text]
-
Hemphill, A., Affolter, M., and Seebeck, T.
(1992)
J. Cell Biol.
117,
95-103
[Abstract/Free Full Text]
-
Müller, N., Hemphill, A., Imboden, M., Duvallet, G., Dwinger, R. H., and Seebeck, T.
(1992)
Parasitology
104,
111-120
-
Imboden, M., Müller, N., Hemphill, A., Mattioli, R., and Seebeck, T.
(1995)
Parasitology
110,
249-258
-
Lee, M. G.-S., Bihain, B. E., Russell, D. G., Deckelbaum, R. J., and Van der Ploeg, L. H. T.
(1990)
Mol. Cell. Biol.
10,
4506-4517
[Abstract/Free Full Text]
-
Lee, M. G.-S., Russell, D. G., D'Alesandro, P. A., and Van der Ploeg, L. H. T.
(1994)
J. Biol. Chem.
269,
8408-8415
[Abstract/Free Full Text]
-
Dame, J. B., Williams, J. L., McCutchan, T. F., Weber, J. L., Wirtz, R. A., Hockmeyer, W. T., Maloy, W. L., Haynes, J. D., Schneider, I., Roberts, D., Sanders, G. S., Reddy, E. P., Diggs, C. L., and Miller, L. H.
(1984)
Science
225,
593-599
[Abstract/Free Full Text]
-
Cowman, A. F., Saint, R. B., Coppel, R. L., Brown, G. V., Anders, R. F., and Kemp, D. J.
(1985)
Cell
40,
775-783
[CrossRef][Medline]
[Order article via Infotrieve]
-
Flaverloro, J. M., Coppel, R. L., Cocoran, L. M., Foote, S. J., Brown, G. V., Anders, R. F., and Kemp, D. J.
(1986)
Nucleic Acids Res.
14,
8265-8277
[Abstract/Free Full Text]
-
Stahl, H. D., Crewther, P. E., Anders, R. F., Brown, G. V., Coppel, R. L., Bianco, A. E., Mitchell, G. F., and Kemp, D. J.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
543-547
[Abstract/Free Full Text]
-
Pollevick, G. D., Affranchino, J. L., Frasch, A. C. C., and Sanches, D. O.
(1991)
Mol. Biochem. Parasitol.
47,
247-250
[CrossRef][Medline]
[Order article via Infotrieve]
-
Anders, R. F.
(1986)
Parasite Immunol.
8,
529-539
[Medline]
[Order article via Infotrieve]
-
Schofield, L.
(1991)
Parasitol. Today
7,
99-105
[CrossRef][Medline]
[Order article via Infotrieve]
-
Coppens, I., Bastin, Courtoy, P. J., Baudhuin, P., and Opperdoes, F. R.
(1991)
Biochem. Biophys. Res. Commun.
178,
185-191
[CrossRef][Medline]
[Order article via Infotrieve]
-
Büchel, D. E., Gronenborn, B., and Müller-Hill, B.
(1980)
Nature
283,
541-545
[CrossRef][Medline]
[Order article via Infotrieve]
-
Welply, J. K., Shenbagamurthi, P., Lennarz, W. J., and Naider, F.
(1983)
J. Biol. Chem.
258,
11856-11863
[Abstract/Free Full Text]
-
Engelman, D. M., Seitz, T. A., and Goldman, A.
(1986)
Annu. Rev. Biophys. Biophys. Chem.
15,
321-353
[CrossRef][Medline]
[Order article via Infotrieve]
-
Blobel, G.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
1496-1500
[Abstract/Free Full Text]
-
Bogner, W., Aquila, H., and Klingenberg, M.
(1986)
Eur. J. Biochem.
161,
611-620
[Medline]
[Order article via Infotrieve]
-
Aquila, H., Link, T. A., and Klingenberg, M.
(1987)
FEBS Lett.
212,
1-9
[CrossRef][Medline]
[Order article via Infotrieve]
-
Brickman, M. J., and Balber, A. E.
(1994)
J. Cell Sci.
107,
3191-3200
[Abstract]
Volume 272, Number 46,
Issue of November 14, 1997
pp. 29212-29221
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Atrih, J. M. Richardson, A. R. Prescott, and M. A. J. Ferguson
Trypanosoma brucei Glycoproteins Contain Novel Giant Poly-N-acetyllactosamine Carbohydrate Chains
J. Biol. Chem.,
January 14, 2005;
280(2):
865 - 871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-L. Chung, M. Carrington, and M. C. Field
Cytoplasmic Targeting Signals in Transmembrane Invariant Surface Glycoproteins of Trypanosomes
J. Biol. Chem.,
December 24, 2004;
279(52):
54887 - 54895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Roper, M. L. S. Guther, K. G. Milne, and M. A. J. Ferguson
Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei
PNAS,
April 30, 2002;
99(9):
5884 - 5889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pal, B. S. Hall, D. N. Nesbeth, H. I. Field, and M. C. Field
Differential Endocytic Functions of Trypanosoma brucei Rab5 Isoforms Reveal a Glycosylphosphatidylinositol-specific Endosomal Pathway
J. Biol. Chem.,
March 8, 2002;
277(11):
9529 - 9539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. McConville, K. A. Mullin, S. C. Ilgoutz, and R. D. Teasdale
Secretory Pathway of Trypanosomatid Parasites
Microbiol. Mol. Biol. Rev.,
March 1, 2002;
66(1):
122 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yang, D. G. Russell, B. Zheng, M. Eiki, and M. G.-S. Lee
Sequence Requirements for Trafficking of the CRAM Transmembrane Protein to the Flagellar Pocket of African Trypanosomes
Mol. Cell. Biol.,
July 15, 2000;
20(14):
5149 - 5163.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. P. Nolan, D. G. Jackson, M. J. Biggs, E. D. Brabazon, A. Pays, F. Van Laethem, F. Paturiaux-Hanocq, J. F. Elliot, H. P. Voorheis, and E. Pays
Characterization of a Novel Alanine-rich Protein Located in Surface Microdomains in Trypanosoma brucei
J. Biol. Chem.,
February 11, 2000;
275(6):
4072 - 4080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Lingnau, R Zufferey, M Lingnau, and D. Russell
Characterization of tGLP-1, a Golgi and lysosome-associated, transmembrane glycoprotein of African trypanosomes
J. Cell Sci.,
January 9, 1999;
112(18):
3061 - 3070.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Field, M. Farjah, A. Pal, K. Gull, and M. C. Field
Complexity of Trypanosomatid Endocytosis Pathways Revealed by Rab4 and Rab5 Isoforms in Trypanosoma brucei
J. Biol. Chem.,
November 27, 1998;
273(48):
32102 - 32110.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|